|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.91/-0.99
|
企业价值
14.33M
|
资产负债 |
每股账面净值
0.56
|
现金流量 |
现金流量率
--
|
损益表 |
收益
0
|
每股收益
0.02
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/01/11 16:32 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatmentsthat harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. |